All Industries

Top Therapeutics Companies

963 Therapeutics companies, sorted by total funding raised.

AbCellera BiologicsIPO

Biopharmaceutical company developing antibody-based therapeutics for biopharma partners.

Vancouver, Canada501–1000Biotech, Healthcare
Series BTotal funding$115.8MMay 2020
VitriVax
Boulder, United States51–200Biotech, Healthcare
Series CTotal funding$114.2MNov 2026
KALA BIOIPO

KALA BIO is a clinical-stage biopharmaceutical company focused on developing treatments for rare ...

Arlington, United States1–10Biotech, Healthcare
Venture RoundTotal funding$113.2MApr 2016
Myricx Bio

Biotech company focused on cell and gene therapy development.

London, United Kingdom1–10Biotech, Therapeutics
Venture RoundTotal funding$113.0MJul 2024
Atara BiotherapeuticsIPO

Clinical-stage allogeneic T-cell immunotherapy company developing off-the-shelf cell therapies fo...

Thousand Oaks, United States201–500Biotech, Oncology
Series BTotal funding$110.5MJan 2014
Dispatch Biotherapeutics

Clinical-stage immunotherapy company developing the Flare platform to expand curative potential o...

Philadelphia, United States51–200Biotech, Oncology
Series ATotal funding$106.0MJul 2025
Click Therapeutics

Click Therapeutics develops, validates, and commercializes prescription digital therapeutics, del...

New York, United States51–200Digital Health, Therapeutics
Series DTotal funding$102.0MApr 2026
Catalyst BiosciencesAcquired

Clinical-stage company now operating as Gyre Therapeutics, developing treatments for organ fibros...

South San Francisco, United States11–50Biotech, Therapeutics
Corporate RoundTotal funding$100.4MJan 2011
Alzheon

Alzheon develops investigational treatments for Alzheimer's disease and other neurodegenerative d...

Framingham, United StatesBiotech, Healthcare
Series ETotal funding$100.0MJun 2024
NightstarAcquired

Private biopharmaceutical company focused on the development of therapies for retinal dystrophies.

Oxford, United Kingdom51–200Biotech, Healthcare
Series CTotal funding$99.1MJun 2017
IconOVir Bio

IconOVir Bio is a biotechnology company pioneering next-generation oncolytic virus therapies to t...

San Diego, United States11–50Biotech, Drug Discovery
Venture RoundTotal funding$97.2MJun 2024
Antios Therapeutics

Antios Therapeutics has developed capsid assembly modulators as potential treatments for patients...

Atlanta, United States11–50Biotech, Therapeutics
Series BTotal funding$96.0MApr 2021
Cajal Neuroscience

Cajal Therapeutics develops small molecule and RNA medicines that restore iron homeostasis for an...

Seattle, United StatesBiotech, Healthcare
Series ATotal funding$96.0MNov 2022
Bonum Therapeutics

Utilizes allosteric regulation to create targeted, highly active, and less toxic medicines

Seattle, United States11–50Biotech, Drug Discovery
Series ATotal funding$93.0M
Gritstone Bio

Cancer immunotherapy company developing next-generation, personalized cancer therapeutics

Emeryville, United States201–500Biotech, Oncology
Series BTotal funding$92.7MSep 2017
TwoStep Therapeutics

TwoStep Therapeutics is developing a pipeline built around a versatile peptide that selectively b...

San Carlos, United States1–10Biotech, Drug Discovery
Series ATotal funding$90.1MSep 2026
Gigagen, Inc.

R&D company with 6 SBIR/STTR awards from Department of Health and Human Services.

South San Francisco, United States1–10Biotech, Genomics
Corporate RoundTotal funding$90.0MMar 2021
Maxion Therapeutics

Biotech developing antibody-based KnotBody therapeutics targeting ion channels and GPCRs to treat...

Cambridge, United Kingdom11–50Life Sciences, Biotech
Series ATotal funding$88.0MMar 2025
Auron Therapeutics

Auron Therapeutics is a clinical-stage biotechnology company targeting cell-state plasticity to i...

Newton, United States11–50Biotech, Healthcare
Series BTotal funding$87.8MFeb 2025
Amicus TherapeuticsAcquired

Oral pharmacological chaperone protein therapies to address diseases that result from protein mis...

Cranbury, United States501–1000Biotech, Drug Discovery
Venture RoundTotal funding$86.0MJan 2006
ReceptosAcquired

Biopharmaceutical company that developed immune-inflammatory therapies, notably ozanimod (RPC-106...

San Diego, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$85.8MMar 2012
Commit Biologics

Commit Biologics is a biotech spin-out from Aarhus University founded in 2021. The Commit team co...

Aarhus, Denmark11–50Biotech, Drug Discovery
SeedTotal funding$85.1MNov 2026
Code Biotherapeutics

A next-generation gene therapy company pioneering the development of targeted non-viral gene ther...

Hatfield, United States11–50Biotech, Therapeutics
Series ATotal funding$85.0MJun 2022
Tempest TherapeuticsIPO

A clinical-stage oncology company advancing small molecules that combine both targeted and immune...

Brisbane, United States11–50Biotech, Drug Discovery
Private EquityTotal funding$85.0MApr 2022
Tentarix Biotherapeutics

Tentarix Biotherapeutics develops conditionally active multispecific biologics designed to reach ...

San Diego, United States11–50Biotech, Oncology
Series BTotal funding$85.0MSep 2023